au.\*:("DE CLERCQ, Erik")
Results 1 to 25 of 274
Selection :
The AMD3100 story : The path to the discovery of a stem cell mobilizer (Mozobil)DE CLERCQ, Erik.Biochemical pharmacology. 2009, Vol 77, Num 11, pp 1655-1664, issn 0006-2952, 10 p.Article
Antiviral drugs in current clinical useDE CLERCQ, Erik.Journal of clinical virology. 2004, Vol 30, Num 2, pp 115-133, issn 1386-6532, 19 p.Article
New developments in anti-HIV chemotherapyDE CLERCQ, Erik.Current medicinal chemistry. 2001, Vol 8, Num 13, pp 1543-1572, issn 0929-8673Article
Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsDE CLERCQ, Erik.Clinical microbiology reviews (Print). 2001, Vol 14, Num 2, issn 0893-8512, 3, 382-397 [16 p.]Article
A 40-Year Journey in Search of Antiviral ChemotherapyDE CLERCQ, Erik.Annual review of pharmacology and toxicology (Print). 2011, Vol 51, pp 1-24, issn 0362-1642, 24 p.Article
Anti-HIV drugs : 25 compounds approved within 25 years after the discovery of HIVDE CLERCQ, Erik.International journal of antimicrobial agents (Print). 2009, Vol 33, Num 4, pp 307-320, issn 0924-8579, 14 p.Article
Antimicrobials : Recent highlights in the development of new antiviral drugsDE CLERCQ, Erik.Current opinion in microbiology. 2005, Vol 8, Num 5, pp 552-560, issn 1369-5274, 9 p.Article
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infectionsDE CLERCQ, Erik.Clinical microbiology reviews (Print). 2003, Vol 16, Num 4, issn 0893-8512, 1, 569-596 [29 p.]Article
Cidofovir in the treatment of poxvirus infectionsDE CLERCQ, Erik.Antiviral research. 2002, Vol 55, Num 1, pp 1-13, issn 0166-3542Article
Highlights in the Discovery of Antiviral Drugs: A Personal RetrospectiveDE CLERCQ, Erik.Journal of medicinal chemistry (Print). 2010, Vol 53, Num 4, pp 1438-1450, issn 0022-2623, 13 p.Article
New approaches toward anti-HIV chemotherapyDE CLERCQ, Erik.Journal of medicinal chemistry (Print). 2005, Vol 48, Num 5, pp 1297-1313, issn 0022-2623, 17 p.Article
Antiviral research at the Rega Institute (KU Leuven), now 50 years oldDE CLERCQ, Erik.Antiviral chemistry & chemotherapy. 2004, Vol 15, Num 5, pp 223-233, issn 0956-3202, 11 p.Article
New inhibitors of human cytomegalovirus (HCMV) on the horizonDE CLERCQ, Erik.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 5, pp 1079-1083, issn 0305-7453, 5 p.Article
Hamao Umezawa Memorial Award Lecture : 'An Odyssey in the viral chemotherapy field'DE CLERCQ, Erik.International journal of antimicrobial agents. 2001, Vol 18, Num 4, pp 309-328, issn 0924-8579Article
The acyclic nucleoside phosphonates from inception to clinical use : Historical perspectiveDE CLERCQ, Erik.Antiviral research. 2007, Vol 75, Num 1, pp 1-13, issn 0166-3542, 13 p.Article
Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in miceNEYTS, Johan; DE CLERCQ, Erik.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 1, pp 84-87, issn 0066-4804Article
The cyclohexene ring as bioisostere of a furanose ring: Synthesis and antiviral activity of cyclohexenyl nucleosidesHERDEWIJN, Piet; DE CLERCQ, Erik.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 12, pp 1591-1597, issn 0960-894XArticle
New developments in anti-HIV chemotherapyDE CLERCQ, Erik.Il Farmaco (Pavia). 2001, Vol 56, Num 1-2, pp 3-12, issn 0014-827XConference Paper
New Therapeutic Approaches Targeted at the Late Stages of the HIV-1 Replication CycleYAN JIANG; XINYONG LIU; DE CLERCQ, Erik et al.Current medicinal chemistry. 2011, Vol 18, Num 1, pp 16-28, issn 0929-8673, 13 p.Article
Synthesis and antiviral activity evaluation of acyclic 2'-azanucleosides bearing a phosphonomethoxy function in the side chainKOSZYTKOWSKA-STAWINSKA, Mariola; DE CLERCQ, Erik; BALZARINI, Jan et al.Bioorganic & medicinal chemistry. 2009, Vol 17, Num 11, pp 3756-3762, issn 0968-0896, 7 p.Article
Cinnamacrins A-C, cinnafragrin D and cytostatic metabolites with α-glucosidase inhibitory activity from Cinnamosma macrocarpaHARINANTENAINA, Liva; ASAKAWA, Yoshinori; DE CLERCQ, Erik et al.Journal of natural products (Print). 2007, Vol 70, Num 2, pp 277-282, issn 0163-3864, 6 p.Article
In search of effective anti-HHV-6 agentsDE CLERCQ, Erik; NAESENS, Lieve.Journal of clinical virology. 2006, Vol 37, issn 1386-6532, S82-S86, SUP1Conference Paper
Viral bioterrorism and biodefenseDE CLERCQ, Erik; KERN, Earl R.Antiviral research. 2003, Vol 57, Num 1-2, issn 0166-3542, 152 p.Serial Issue
Angiogenesis : regulators and clinical applicationsLIEKENS, Sandra; DE CLERCQ, Erik; NEYTS, Johan et al.Biochemical pharmacology. 2001, Vol 61, Num 3, pp 253-270, issn 0006-2952Article
Blocking Nuclear Import of Pre-Integration Complex: An Emerging Anti-HIV-1 Drug Discovery ParadigmPENG ZHAN; XINYONG LIU; DE CLERCQ, Erik et al.Current medicinal chemistry. 2010, Vol 17, Num 6, pp 495-503, issn 0929-8673, 9 p.Article